+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Parenteral Nutrition Market - Global Forecast 2026-2032- Product Image
Parenteral Nutrition Market - Global Forecast 2026-2032- Product Image
Sale

Parenteral Nutrition Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968576
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Parenteral Nutrition Market is projected to reach USD 8.57 Billion in 2026. It is expected to continue growing at a CAGR of 5.74%, reaching USD 12.08 Billion by 2032.

Parenteral nutrition (PN), including total parenteral nutrition and supplemental parenteral nutrition, is an essential therapy for patients who cannot meet nutritional requirements through the gastrointestinal tract. Demand is supported by clinically defined need across neonatal intensive care, oncology, critical care, intestinal failure, inflammatory bowel disease, major surgery, and long-term home parenteral nutrition programs.

The parenteral nutrition market is shaped by sterile injectable manufacturing capacity, amino acid solutions, dextrose, electrolytes, vitamins, trace elements, lipid emulsions, multi-chamber bags, automated compounding, and hospital nutrition support teams. Adoption is closely tied to survival in complex care settings, the expansion of home infusion services, and guideline-driven emphasis on individualized nutrition therapy to reduce complications, preserve lean body mass, and support recovery.

Transformative Shifts in the Parenteral Nutrition Landscape

The landscape is shifting from standardized hospital-based PN toward personalized, protocol-driven, and increasingly home-enabled nutrition therapy. Clinical guidelines from ASPEN and ESPEN reinforce appropriate patient selection, infection prevention, glycemic management, and monitoring for refeeding risk, electrolyte imbalance, liver complications, and catheter-related bloodstream infections.

Manufacturers and providers are also adapting to persistent sterile injectable supply constraints, stronger quality requirements, and demand for ready-to-use multi-chamber bags that can reduce compounding burden. At the same time, specialty pharmacies and home infusion providers are investing in training, remote monitoring, and logistics capabilities to support safe parenteral nutrition administration outside acute care settings.

Cumulative Impact of Artificial Intelligence on Parenteral Nutrition

Artificial intelligence is beginning to influence parenteral nutrition through clinical decision support, compounding workflow optimization, inventory planning, and adverse-event surveillance. EHR-integrated tools can help identify patients at nutrition risk, flag electrolyte abnormalities, support dose calculations, and prompt monitoring, while final PN prescribing remains a clinician-led process requiring pharmacist, dietitian, and physician oversight.

The cumulative impact of AI is expected to be strongest where data quality is high and governance is mature. Automated checks for osmolarity, compatibility, dosing limits, renal or hepatic adjustments, and inventory availability can reduce avoidable variation. However, AI adoption must align with validated clinical protocols, cybersecurity requirements, medication safety standards, and transparent audit trails to avoid unsafe automation in a high-risk sterile injectable therapy.

Key Regional Insights for Parenteral Nutrition

Asia-Pacific is gaining momentum as hospital infrastructure expands, critical care capacity improves, and countries such as China, India, Japan, Australia, and South Korea invest in advanced clinical nutrition. Japan and Australia have mature nutrition support practices and established hospital pharmacy governance, while China and India are seeing rising demand from oncology, gastrointestinal surgery, neonatal care, and private hospital networks.

North America remains one of the most developed PN regions, supported by established home infusion reimbursement pathways, hospital compounding standards, nutrition support teams, and a large base of patients with complex chronic disease. Europe benefits from ESPEN-aligned clinical practice, sophisticated home parenteral nutrition programs, pharmacovigilance frameworks, and demand for multi-chamber bags, while Latin America is advancing through private healthcare investment, tertiary care expansion, and improving access in Brazil and Mexico.

The Middle East is expanding PN utilization through tertiary hospitals, medical tourism hubs, and government investment in specialized care, particularly in GCC markets. Africa remains comparatively underpenetrated because of infrastructure, affordability, cold-chain, and sterile compounding limitations, but targeted investment in neonatal care, oncology, intensive care, and hospital pharmacy capability is creating long-term opportunity.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN presents a mixed but promising PN environment, with Singapore, Thailand, and Malaysia leading in hospital capability, clinical nutrition adoption, and medical tourism, while Indonesia, Vietnam, and the Philippines expand access through broader healthcare investment. GCC countries are accelerating adoption through high-acuity hospital systems, specialist centers, medical tourism strategies, and government-backed modernization programs.

The European Union is a key regulatory and clinical hub, supported by harmonized quality expectations, pharmacovigilance, sterile preparation standards, and well-established clinical nutrition societies. BRICS countries offer scale and rising demand, especially through China, India, and Brazil, but local manufacturing resilience, affordability, reimbursement consistency, and hospital pharmacy capacity remain decisive factors.

G7 markets account for advanced PN use because of mature hospital systems, home infusion networks, specialist nutrition services, and high adoption of medication safety standards. NATO countries overlap significantly with high-income healthcare systems in North America and Europe, where supply security, sterile injectable resilience, procurement diversification, and critical care readiness have become strategic priorities.

Key Country Insights for Parenteral Nutrition Demand

The United States leads in home parenteral nutrition, specialty infusion, and automated compounding adoption, with demand shaped by intestinal failure, oncology, critical care, surgical recovery, and neonatal intensive care. Canada follows a publicly funded, protocol-driven model with strong clinical oversight, while Mexico and Brazil are expanding access through private hospitals, tertiary centers, oncology services, and gradual improvements in hospital pharmacy capability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain have well-developed clinical nutrition practices supported by specialist teams, home PN pathways, and safety-focused hospital pharmacy systems. Germany and France demonstrate strong specialty pharmacy and hospital infrastructure, the United Kingdom benefits from established intestinal failure services, Italy and Spain show broad use in tertiary care, and Russia maintains demand across large hospital networks, although access and procurement dynamics vary by region.

China and India represent major demand centers as surgical volumes, cancer care, intensive care services, and private hospital networks expand. Japan and South Korea have advanced hospital systems, strong quality expectations, and established clinical nutrition practices, while Australia combines mature home infusion capabilities with strong clinical governance for long-term PN patients.

Actionable Recommendations for Parenteral Nutrition Leaders

Industry leaders should prioritize supply resilience by diversifying sterile injectable sourcing, strengthening quality systems, and improving visibility into amino acids, lipid emulsions, electrolytes, vitamins, and trace elements. Providers should standardize PN protocols, invest in nutrition support teams, and use validated compounding checks to reduce medication errors, metabolic complications, and catheter-related infections.

Manufacturers and service providers should expand ready-to-use multi-chamber bag portfolios while preserving customization for complex patients. Strategic advancement will come from integrated hospital-to-home pathways, pharmacist-led monitoring, patient education, remote follow-up, and evidence generation demonstrating fewer complications, shorter hospital stays, and improved continuity of care.

Research Methodology for Parenteral Nutrition Analysis

This executive summary is developed from a structured review of clinical nutrition guidelines, regulatory standards, healthcare infrastructure indicators, sterile injectable supply dynamics, hospital pharmacy practices, and published evidence on parenteral nutrition safety and outcomes. The analysis emphasizes verifiable drivers such as disease burden, hospital capacity, reimbursement maturity, clinical governance, and home infusion readiness.

Market interpretation uses triangulation across therapy guidelines, manufacturer portfolios, healthcare policy signals, clinical practice patterns, regional access conditions, sterile preparation requirements, and technology adoption trends. Insights are qualitative and evidence-led, avoiding unsupported numerical claims while focusing on factors that reliably influence parenteral nutrition demand, adoption, and competitive positioning.

Conclusion: Strategic Outlook for Parenteral Nutrition

Parenteral nutrition remains a critical intervention for patients who cannot safely or adequately receive enteral nutrition. The market is advancing through individualized formulations, safer compounding, home infusion growth, lipid emulsion innovation, ready-to-use multi-chamber bags, and stronger clinical governance across hospitals and specialty pharmacies.

Future competitiveness will depend on reliable sterile injectable supply, validated digital tools, compliance with medication safety standards, and integrated care models that connect acute treatment with long-term monitoring. Organizations that combine clinical evidence, operational resilience, and patient-centered delivery will be best positioned in the evolving parenteral nutrition market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Parenteral Nutrition Market, by Product Type
7.1. Introduction
7.2. Peripheral Parenteral Nutrition
7.3. Total Parenteral Nutrition
8. Parenteral Nutrition Market, by Composition
8.1. Introduction
8.2. Amino Acid Solution
8.3. Carbohydrate Solution
8.4. Electrolyte Solution
8.5. Lipid Emulsion
8.6. Vitamin And Trace Element Solutions
9. Parenteral Nutrition Market, by Route Of Administration
9.1. Introduction
9.2. Central Line
9.3. Peripheral Line
10. Parenteral Nutrition Market, by Therapy Duration
10.1. Introduction
10.2. Short Term
10.3. Long Term
11. Parenteral Nutrition Market, by Delivery Mode
11.1. Introduction
11.2. Custom
11.2.1. On Site Compounding
11.2.2. Outsourced Compounding
11.3. Pre Mixed
11.3.1. Multi Chamber Bags
11.3.2. Single Chamber Bags
12. Parenteral Nutrition Market, by Age Group
12.1. Introduction
12.2. Pediatric
12.3. Adult
12.4. Geriatric
13. Parenteral Nutrition Market, by Application
13.1. Introduction
13.2. Critical Care
13.3. Oncology Nutrition
13.4. Surgical Nutrition
14. Parenteral Nutrition Market, by End User
14.1. Introduction
14.2. Clinics
14.3. Homecare
14.4. Hospitals
15. Parenteral Nutrition Market, by Region
15.1. Asia-Pacific
15.2. North America
15.3. Latin America
15.4. Europe
15.5. Middle East
15.6. Africa
16. Parenteral Nutrition Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Parenteral Nutrition Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. Aculife Healthcare Pvt. Ltd.
19.3. Ajinomoto Co., Inc.
19.4. Albert David Limited
19.5. Amanta Healthcare
19.6. American Regent
19.7. Anhui Medipharm Co., Ltd.
19.8. Axa Parenterals Ltd.
19.9. B. Braun Melsungen AG
19.10. Baxter International Inc.
19.11. Beximco Pharmaceuticals Ltd.
19.12. BML Parenteral Drugs
19.13. Claris Lifesciences Limited
19.14. Danone Nutricia
19.15. Eurofarma
19.16. Fresenius Kabi AG
19.17. Grifols S.A.
19.18. ICU Medical, Inc.
19.19. JW Pharmaceutical Corporation
19.20. Medtronic
19.21. Nestlé Health Science
19.22. Nipro Corporation
19.23. Otsuka Pharmaceutical Co., Ltd.
19.24. Pfizer Inc.
19.25. Pharamed Healthcare
19.26. Sichuan Kelun Pharmaceutical Co., Ltd.
19.27. Sino-Swed Pharmaceutical Corp.
19.28. Terumo Corporation
19.29. Teva Pharmaceutical Industries
19.30. Vifor Pharma
List of Figures
FIGURE 1. GLOBAL PARENTERAL NUTRITION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PARENTERAL NUTRITION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PARENTERAL NUTRITION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PARENTERAL NUTRITION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PARENTERAL NUTRITION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL TOTAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL AMINO ACID SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL AMINO ACID SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL AMINO ACID SOLUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CARBOHYDRATE SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CARBOHYDRATE SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CARBOHYDRATE SOLUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ELECTROLYTE SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ELECTROLYTE SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ELECTROLYTE SOLUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL LIPID EMULSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LIPID EMULSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LIPID EMULSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL VITAMIN AND TRACE ELEMENT SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL VITAMIN AND TRACE ELEMENT SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL VITAMIN AND TRACE ELEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CENTRAL LINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CENTRAL LINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CENTRAL LINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PERIPHERAL LINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PERIPHERAL LINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PERIPHERAL LINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SHORT TERM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SHORT TERM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SHORT TERM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL LONG TERM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL LONG TERM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LONG TERM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CUSTOM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CUSTOM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CUSTOM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ON SITE COMPOUNDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ON SITE COMPOUNDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ON SITE COMPOUNDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL OUTSOURCED COMPOUNDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL OUTSOURCED COMPOUNDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL OUTSOURCED COMPOUNDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PRE MIXED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PRE MIXED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PRE MIXED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MULTI CHAMBER BAGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MULTI CHAMBER BAGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL MULTI CHAMBER BAGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SINGLE CHAMBER BAGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SINGLE CHAMBER BAGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL SINGLE CHAMBER BAGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CRITICAL CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CRITICAL CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CRITICAL CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SURGICAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SURGICAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SURGICAL NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOMECARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HOMECARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL HOMECARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 125. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 126. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 127. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 128. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 129. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 130. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 131. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 132. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 133. EUROPE PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 140. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 147. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 148. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 149. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 150. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 151. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 152. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 153. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 154. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 159. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 160. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 161. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 162. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 163. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 164. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 165. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 166. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. ASEAN PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. GCC PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. GCC PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 170. GCC PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 171. GCC PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 172. GCC PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 173. GCC PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 174. GCC PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 175. GCC PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 176. GCC PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 177. GCC PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. GCC PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. BRICS PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. BRICS PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. BRICS PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 193. BRICS PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 194. BRICS PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 195. BRICS PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 196. BRICS PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 197. BRICS PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 198. BRICS PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 199. BRICS PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. BRICS PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. G7 PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. G7 PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 203. G7 PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 204. G7 PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 205. G7 PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 206. G7 PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 207. G7 PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 208. G7 PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 209. G7 PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 210. G7 PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 211. G7 PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 212. NATO PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. NATO PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 214. NATO PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 215. NATO PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 216. NATO PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 217. NATO PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 218. NATO PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 219. NATO PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 220. NATO PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 221. NATO PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 222. NATO PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. CANADA PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 236. CANADA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 237. CANADA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 238. CANADA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 239. CANADA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 240. CANADA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 241. CANADA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 242. CANADA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 243. CANADA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 244. CANADA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. CANADA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. MEXICO PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 247. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 249. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 250. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 251. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 252. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 253. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 254. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 255. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 262. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 263. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 264. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 265. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 266. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 267. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 279. GERMANY PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 281. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 282. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 283. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 284. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 285. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 286. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 287. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 288. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. FRANCE PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 293. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 294. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 295. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 296. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 297. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 298. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 299. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 305. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 306. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 307. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 308. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 309. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 310. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 311. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 312. ITALY PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. ITALY PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 314. ITALY PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 315. ITALY PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 316. ITALY PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 317. ITALY PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 318. ITALY PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 319. ITALY PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 320. ITALY PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 321. ITALY PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. ITALY PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. SPAIN PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 324. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 325. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 326. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 327. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 328. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 329. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 330. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 331. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 332. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 333. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 334. CHINA PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 335. CHINA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 336. CHINA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 337. CHINA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 338. CHINA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 339. CHINA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 340. CHINA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 341. CHINA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 342. CHINA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 343. CHINA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 344. CHINA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. INDIA PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 346. INDIA PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 347. INDIA PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 348. INDIA PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 349. INDIA PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 350. INDIA PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 351. INDIA PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 352. INDIA PARENTERAL NUTRITION MARKET SIZE, BY PRE MIXED, 2017-2032 (USD MILLION)
TABLE 353. INDIA PARENTERAL NUTRITION MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 354. INDIA PARENTERAL NUTRITION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 355. INDIA PARENTERAL NUTRITION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 356. JAPAN PARENTERAL NUTRITION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 357. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 358. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY COMPOSITION, 2017-2032 (USD MILLION)
TABLE 359. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 360. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY THERAPY DURATION, 2017-2032 (USD MILLION)
TABLE 361. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY DELIVERY MODE, 2017-2032 (USD MILLION)
TABLE 362. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY CUSTOM, 2017-2032 (USD MILLION)
TABLE 363. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY

Companies Mentioned

  • Abbott Laboratories
  • Aculife Healthcare Pvt. Ltd.
  • Ajinomoto Co., Inc.
  • Albert David Limited
  • Amanta Healthcare
  • American Regent
  • Anhui Medipharm Co., Ltd.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Beximco Pharmaceuticals Ltd.
  • BML Parenteral Drugs
  • Claris Lifesciences Limited
  • Danone Nutricia
  • Eurofarma
  • Fresenius Kabi AG
  • Grifols S.A.
  • ICU Medical, Inc.
  • JW Pharmaceutical Corporation
  • Medtronic
  • Nestlé Health Science
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Pharamed Healthcare
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sino-Swed Pharmaceutical Corp.
  • Terumo Corporation
  • Teva Pharmaceutical Industries
  • Vifor Pharma

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 12.08 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Parenteral Nutrition - Global Strategic Business Report - Product Image

Parenteral Nutrition - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type, Stage Type, Indication, Sales Channel, Region, and Growth Forecasts, 2026-2033 - Product Image

Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type, Stage Type, Indication, Sales Channel, Region, and Growth Forecasts, 2026-2033

  • Report
  • 190 Pages
  • Global
From
Parenteral Nutrition Market Report by Nutrient Type, End User, and Region 2026-2034 - Product Image

Parenteral Nutrition Market Report by Nutrient Type, End User, and Region 2026-2034

  • Report
  • 140 Pages
  • Global
From
Parenteral Nutrition Market Report 2026 - Product Image

Parenteral Nutrition Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Parenteral PrEP Market - Global Forecast 2026-2032 - Product Image

Parenteral PrEP Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.